CUE CARD CONSULT #42

You may see this in your practice soon. Don't be caught guessing.

Click here and scroll down for previous newsletters.

1. Pictured Counselling Cue Card: a free sample of our counselling reference

2. Patient Consultation: exactly what a pharmacist may say to a patient picking up this medication, with formatting to show where the information is coming from on the cue card

Clearly, there are nuances that may not be captured in this format. The goal here is to provide you with an example of how a pharmacist may counsel a patient. Basic counselling tactics (e.g. showing the patient the labeled medication as you read it, having the patient repeat the information in their own words, double-checking allergies, and so on) may not be depicted in the interest of keeping the content concise.

RPh: Hi! Is this medication new for you?

Patient: Yes.

RPh: Ok. What has (prescriber) told you?

Patient: It's in case I get stung by a bee; I am allergic.

RPh: Ok. This medication is called NEFFY or EPINEPHRINE, and you'll take it (as directed). It's in the family of what's called an alpha and beta agonist, but basically it will treat a severe allergic reaction in aro5:04 PMund 5-10 mins. Side effects may include throat irritation, nasal discharge and discomfort, dizziness, and increased heart rate. To use it, simply insert it straight into one nostril using the same side hand (if someone else is using it, ideally the opposite side hand) and press until you hear a snap; avoid sniffing during/after. Generally use it if two systems are affected (e.g. rash + wheezing) or if you're worried you might need it. Always call 911, as it is not a permanent treatment. You can repeat another (new) dose in 5 mins into the same nostril if needed while waiting for paramedics. Store it at room temperature.

RPh: Did you have any questions?

Patient: Does it work slower than the EpiPen?

RPh: Clinically it works just as well, though levels do take slightly longer to reach maximum concentration. There are nasal alternatives for opioid overdose and low blood sugar, and these also are clinically similar to their injectable alternatives.

Patient: Thanks!

We hope you found this useful. Reply with any feedback or topic suggestions; your input helps shape the newsletter.